Skip to content
Disclosery

HARBERT FUND ADVISORS, LLC

Follow

13F filer, CIK 1616659, Birmingham, AL

HARBERT FUND ADVISORS, LLC reported $3,490,587 across 2 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-26-000763

Period
2025-12-31
Reported value
$3.49M
Holdings
2
Top 10 weight
100%
New
0
Sold out
10

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LQDAexited-154,811-$3.52M
FRNMexited-300,000-$3.18M
FENCexited-177,815-$1.66M
TACTreduced-297,607-$1.19M
OCULexited-50,000-$584K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0000919574-26-000763, largest first. % of portfolio is the value over $3,490,587, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INVEINVE TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 785,557 shares; 2024Q4: 785,557 shares; 2025Q1: 785,557 shares; 2025Q2: 785,557 shares; 2025Q3: 785,557 shares; 2025Q4: 785,557 shares 785,557$3.02M86.42%0Timeline
TACTTRANSACT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 640,168 shares; 2024Q4: 640,168 shares; 2025Q1: 640,168 shares; 2025Q2: 640,168 shares; 2025Q3: 416,119 shares; 2025Q4: 118,512 shares 118,512$474K13.58%-297,607Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
LQDALIQUIDIA CORPORATION154,811$3.52Mshares
FRNMPERCEPTIVE CAP SOLUTIONS COR300,000$3.18Mshares
FENCFENNEC PHARMACEUTICALS INC177,815$1.66Mshares
OCULOCULAR THERAPEUTIX INC50,000$584Kshares
NTSKNETSKOPE INC15,000$341Kshares
AMZNAMAZON COM INC1,507$331Kshares
TSMTAIWAN SEMICONDUCTOR MANUFAC1,181$330Kshares
MSFTMICROSOFT CORP535$277Kshares
ONCHU1RT ACQUISITION CORP.10,000$106Kshares
ILLRTRILLER GROUP INC COM33,182$27.5Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-26-000763 base2026-02-13acceptance time not in the bulk data set